LACOSAMIDE
NDC 68462-697, LACOSAMIDE, injection, solution, from GLENMARK PHARMACEUTICALS INC., USA.
- Product NDC
- 68462-697
- Status
- Listed
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220268
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/68462-697 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-697-30 | 68462069730 | 10 VIAL in 1 CARTON (68462-697-30) / 20 mL in 1 VIAL (68462-697-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc
Use it
Look up 68462-697 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-697 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-697. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.